Clinical Endoscopy

Kwang Hyuck Lee

4 Articles

Risk Factors for Pancreatitis and Cholecystitis after Endoscopic Biliary Stenting in Patients with Malignant Extrahepatic Bile Duct Obstruction: Ga Hee Kim, Si Kyong Ryoo, Jae Keun Park, Joo Kyung Park, Kwang Hyuck Lee, Kyu Taek Lee, Jong Kyun Lee; Clin Endosc 2019;52(6):598-605. Published online May 28, 2019; DOI: https://doi.org/10.5946/ce.2018.177

Background
/Aims: For the treatment of malignant biliary obstruction, endoscopic retrograde biliary drainage (ERBD) has been widely accepted as a standard procedure. However, post-ERBD complications can affect the lives of patients. The purpose of this study was to identify the predictive factors for these complications, including the patient’s status, cancer status, and stent type.
Methods
This was a retrospective analysis conducted in a single tertiary hospital from January 2007 to July 2017. The following variables were evaluated: sex, age, body mass index, cancer type, history of pancreatitis, gallbladder stone, previous biliary stenting, precut papillotomy, stent type, contrast injection into the pancreatic duct or gallbladder, cystic duct invasion by the tumor, and occlusion of the cystic duct orifice by a metal stent.
Results
Multivariate analysis showed that contrast injection into the pancreatic duct was a risk factor for pancreatitis. Patients with a history of bile drainage showed a lower risk of pancreatitis. For cholecystitis, the analysis revealed contrast injection into the gallbladder and cystic duct invasion by the tumor as important predictive factors. Metal stents showed a greater risk of post-procedure pancreatitis than plastic stents, but did not affect the incidence of cholecystitis.
Conclusions
Considering that contrast injection is the most important factor for both complications, a careful approach by the physician is essential in preventing the occurrence of any complications. Further, choosing the type of stent is an important factor for patients at a risk of post-procedure pancreatitis.

Citations

Citations to this article as recorded by

Risk factors for biliary tract events during elective cholecystectomy waiting time after endoscopic retrograde cholangiopancreatography for choledocholithiasis
Tatsunori Satoh, Junichi Kaneko, Shinya Kawaguchi, Yuya Ishiguro, Shinya Endo, Naofumi Shirane, Hideyuki Kanemoto, Takanori Yamada, Kazuya Ohno
DEN Open.2025;[Epub] CrossRef
Endoscopic Management of Malignant Biliary Obstruction
Woo Hyun Paik, Do Hyun Park
Gastrointestinal Endoscopy Clinics of North America.2024; 34(1): 127. CrossRef
Computed tomography-based prediction of pancreatitis following biliary metal stent placement with the convolutional neural network
Tsuyoshi Hamada, Koichiro Yasaka, Yousuke Nakai, Rintaro Fukuda, Ryunosuke Hakuta, Kazunaga Ishigaki, Sachiko Kanai, Kensaku Noguchi, Hiroki Oyama, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Naminatsu Takahara, Hiroyuki Isayama, Osamu Abe, Mitsuhiro
Endoscopy International Open.2024; 12(06): E772. CrossRef
Risk Factors Associated with Acute Pancreatitis after Percutaneous Biliary Intervention: We Do Not Know Nearly Enough
Jing Song, Jun Deng, Feng Wen, Piero Chirletti
Gastroenterology Research and Practice.2023; 2023: 1. CrossRef
CT imaging features of bile duct stent complications
Nga T. Nguyen, Hasan A. Khan, Kian Abdul-Baki, Woongsoon Choi, Neel K. Shroff, Zahra Akhtar, Peeyush Bhargava
Clinical Imaging.2023; 103: 109986. CrossRef
Biliary Adverse Events during Neoadjuvant Therapy for Pancreatic Cancer
Sam Z. Thalji, Deemantha Fernando, Kulwinder S. Dua, Srivats Madhavan, Phillip Chisholm, Zachary L. Smith, Mohammed Aldakkak, Kathleen K. Christians, Callisia N. Clarke, Ben George, Mandana Kamgar, Beth A. Erickson, William A. Hall, Douglas B. Evans, Susa
Annals of Surgery.2023;[Epub] CrossRef
Can the laser‐cut covered self‐expandable metallic stent be the first choice for patients with unresectable distal malignant biliary obstruction? (with video)
Yuki Tanisaka, Masafumi Mizuide, Akashi Fujita, Tomoya Ogawa, Hiromune Katsuda, Youichi Saito, Kazuya Miyaguchi, Ryuichiro Araki, Shomei Ryozawa
Journal of Hepato-Biliary-Pancreatic Sciences.2022; 29(5): 585. CrossRef
Percutaneous cholecystostomy for acute cholecystitis after stent insertion in patients with malignant biliary obstruction: clinical outcomes of 107 patients
Woosun Choi, Dong Il Gwon, Jong Woo Kim, Jin Hyoung Kim, Ji Hoon Shin, Gi-Young Ko, Joonho Hur
Acta Radiologica.2022; 63(10): 1315. CrossRef
Prevention of Serious Complications during Endoscopic Ultrasound-Guided Biliary Drainage: A Case-Based Technical Review
Surinder Singh Rana, Jimil Shah, Harish Bhujade, Ujjwal Gorsi, Mandeep Kang, Rajesh Gupta
Journal of Digestive Endoscopy.2022; 13(02): 082. CrossRef
The feasibility of percutaneous transhepatic gallbladder aspiration for acute cholecystitis after self-expandable metallic stent placement for malignant biliary obstruction: a 10-year retrospective analysis in a single center
Akihisa Ohno, Nao Fujimori, Toyoma Kaku, Masayuki Hijioka, Ken Kawabe, Naohiko Harada, Makoto Nakamuta, Takamasa Oono, Yoshihiro Ogawa
Clinical Endoscopy.2022; 55(6): 784. CrossRef
How should a therapeutic strategy be constructed for acute cholecystitis after self-expanding metal stent placement for malignant biliary obstruction?
Mamoru Takenaka, Masatoshi Kudo
Clinical Endoscopy.2022; 55(6): 757. CrossRef
Dilated main pancreatic duct can be a negative predictor of pancreatitis related to biliary SEMS insertion across the papilla
Masahiro Umemura, Eri Shimura, Yusuke Asai, Atsushi Tsuji, Masafumi Nishino, Yurimi Takahashi, Yuzo Sasada, Yasuhiko Saida, Kazuhito Kawata, Ken Sugimoto, Takanori Yamada
Scandinavian Journal of Gastroenterology.2021; 56(7): 865. CrossRef
Cholecystitis after Placement of Covered Self-Expandable Metallic Stents in Patients with Distal Malignant Biliary Obstructions
Masafumi Watanabe, Kosuke Okuwaki, Jun Woo, Mitsuhiro Kida, Hiroshi Imaizumi, Tomohisa Iwai, Hiroshi Yamauchi, Toru Kaneko, Rikiya Hasegawa, Takahiro Kurosu, Naoki Minato, Hiroki Haradome, Wasaburo Koizumi
Clinical Endoscopy.2021; 54(4): 589. CrossRef
Influence of fully covered metal stenting on the risk of post‐endoscopic retrograde cholangiopancreatography pancreatitis: A large multicenter study·
Ming‐Xing Xia, Yi‐Feng Zhou, Ming Zhang, Wei Wang, Jun Wu, Tian‐Tian Wang, Xiao‐Feng Zhang, Bing Hu
Journal of Gastroenterology and Hepatology.2020; 35(12): 2256. CrossRef
Strategies to Overcome Risks Associated with Endoscopic Biliary Stenting
Woo Hyun Paik, Yong-Tae Kim
Clinical Endoscopy.2019; 52(6): 525. CrossRef

6,465 View
175 Download
15 Web of Science
15 Crossref

Present and Future of Endoscopic Ultrasound-Guided Tissue Acquisition in Solid Pancreatic Tumors: Jae Keun Park, Kwang Hyuck Lee; Clin Endosc 2019;52(6):541-548. Published online November 29, 2019; DOI: https://doi.org/10.5946/ce.2019.127

Abstract PDF PubReader ePub

Endoscopic ultrasound-guided tissue acquisition (EUS-TA) is a well-established method for pathological diagnosis of solid pancreatic neoplasm. It can be performed either as EUS-guided fine-needle aspiration (EUS-FNA) or EUS-guided fine-needle biopsy (EUSFNB). The incidence of adverse events related to EUS-TA is less than 1%. The factors that affect the diagnostic accuracy and specimen adequacy include the techniques used, type and size of the needle, competency of endosonographers, presence of cytopathologists/ cytotechnologists, and rapid on-site examination. EUS-TA may contribute to precision medicine through obtaining tissue samples for next-generation sequencing. The current status, several clinical issues for diagnostic yield and adverse events, and future perspectives of EUS-FNA/FNB for diagnosing pancreatic neoplasm have been discussed in this review article.

Citations

Citations to this article as recorded by

Diagnostic performance of EUS-guided tissue acquisition for solid pancreatic lesions ≤10 mm
Yuki Kawasaki, Susumu Hijioka, Yoshikuni Nagashio, Akihiro Ohba, Yuta Maruki, Kotaro Takeshita, Tetsuro Takasaki, Daiki Agarie, Yuya Hagiwara, Hidenobu Hara, Kohei Okamoto, Daiki Yamashige, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Takahiro Mizui, Ta
Endoscopic Ultrasound.2024; 13(2): 115. CrossRef
A combination of faecal and intratumour microbial community profiling reveals novel diagnostic and prognostic biomarkers for pancreatic tumours
Wei Wang, Cheng Qian, Ting Wang, Yuetong Jiang, Yiran Zhou, Kaiyu Liu, Zhiyang Ma, Pengyi Liu, Yichi Wu, Leying Chen, Huaizhi Wang, Tingting Zhou
Clinical and Translational Medicine.2024;[Epub] CrossRef
Molecular Characterization and Xenotransplantation of Pancreatic Cancer Using Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA)
Lilia Antonova, Piriya Paramanthan, Theresa Falls, Marie-Eve Wedge, Justin Mayer, Harman S. Sekhon, John McPherson, Robert E. Denroche, Steven Gallinger, John Cameron Bell, Carolina S. Ilkow, Avijit Chatterjee
Cancers.2024; 16(15): 2721. CrossRef
Endoscopic ultrasound-guided fine-needle biopsy diagnosing pancreatic metastasis seven years after renal leiomyosarcoma resection: a case report
Takuya Okamoto, Shuhei Shintani, Hiromitsu Maehira, Kosuke Hiroe, Shiori Onoda, Hidenori Kimura, Atsushi Nishida, Masaji Tani, Ryoji Kushima, Osamu Inatomi
Clinical Journal of Gastroenterology.2024; 17(6): 1111. CrossRef
How to optimize the diagnostic yield of endoscopic ultrasound-guided fine-needle sampling in solid pancreatic lesions from a technical perspective
Nam Hee Kim, Hong Joo Kim
International Journal of Gastrointestinal Intervention.2023; 12(2): 57. CrossRef
Efficacy of endoscopic ultrasound-guided tissue acquisition for solid pancreatic lesions 20 mm or less in diameter suspected as neuroendocrine tumors or requiring differentiation
Yuki Kawasaki, Susumu Hijioka, Yoshikuni Nagashio, Yuta Maruki, Akihiro Ohba, Kotaro Takeshita, Tetsuro Takasaki, Daiki Agarie, Yuya Hagiwara, Hidenobu Hara, Kohei Okamoto, Daiki Yamashige, Shunsuke Kondo, Chigusa Morizane, Hideki Ueno, Takahiro Mizui, Ta
Journal of Gastroenterology.2023; 58(7): 693. CrossRef
Performance of EUS-FNB in solid pancreatic masses: a lesson from 463 consecutive procedures and a practical nomogram
Nico Pagano, Claudio Ricci, Carlo Ingaldi, Sinan Sadalla, Andrea Fabbri, Laura Alberici, Giovanna Impellizeri, Socrate Pallio, Rocco Maurizio Zagari, Antonio De Leo, Matteo Cescon, Riccardo Casadei
Updates in Surgery.2022; 74(3): 945. CrossRef
Diagnostic Value and Influencing Factors of EUS-FNA in Pancreatic Solid Masses
培君任
Advances in Clinical Medicine.2022; 12(05): 3931. CrossRef
Diagnostic performance of endoscopic ultrasound-guided tissue acquisition by EUS-FNA versus EUS-FNB for solid pancreatic mass without ROSE: a retrospective study
Thanawin Wong, Tanawat Pattarapuntakul, Nisa Netinatsunton, Bancha Ovartlarnporn, Jaksin Sottisuporn, Naichaya Chamroonkul, Pimsiri Sripongpun, Sawangpong Jandee, Apichat Kaewdech, Siriboon Attasaranya, Teerha Piratvisuth
World Journal of Surgical Oncology.2022;[Epub] CrossRef
Safety and Efficacy of Ultrasound-Guided Percutaneous Core Needle Biopsy of Pancreatic and Peripancreatic Lesions Adjacent to Critical Vessels
Sun Hwa Chung, Hyun Ji Kang, Hyo Jeong Lee, Jin Sil Kim, Jeong Kyong Lee
Journal of the Korean Society of Radiology.2021; 82(5): 1207. CrossRef

5,661 View
171 Download
8 Web of Science
10 Crossref

Interventional Endoscopic Ultrasonography: Present and Future: Kwang Hyuck Lee, Jong Kyun Lee; Clin Endosc 2011;44(1):6-12. Published online September 30, 2011; DOI: https://doi.org/10.5946/ce.2011.44.1.6

Abstract PDF PubReader ePub

The technical advances in endoscopic ultrasonograpy (EUS) and accessories have enabled performing EUS-guided intervention in the pancreas and biliary tract. Many research centers have been performing or investigating EUS-guided drainage, EUS-guided celiac plexus neurolysis and block, EUS-guided anastomosis that includes choledocho-enterostomy and choledocho-gastrostomy, EUS-guided ablation and injection therapy mainly for pancreatic neoplasm, EUS-guided photodynamic therapy and EUS-guided brachytherapy. Some of these are currently clinical applications and others are under investigations in clinical studies or animal models. Further detailed randomized controlled clinical trials and the development of materials will bring us into a new era of therapeutic EUS.

Citations

Citations to this article as recorded by

Endoscopic ultrasound-guided ethanol and radiofrequency ablation of pancreatic insulinomas: a systematic literature review
Ghassan El Sayed, Levente Frim, Jamie Franklin, Raymond McCrudden, Charles Gordon, Safa Al-Shamma, Szabolcs Kiss, Péter Hegyi, Bálint Erőss, Péter Jenő Hegyi
Therapeutic Advances in Gastroenterology.2021;[Epub] CrossRef
Echoendoscopic ablative therapy for solid pancreatic tumors
Woo Hyun Paik, Dong Wan Seo
Journal of Digestive Diseases.2017; 18(3): 135. CrossRef
Endoscopic Ultrasound-Guided Treatment beyond Drainage: Hemostasis, Anastomosis, and Others
Jessica L. Widmer, Kahaleh Michel
Clinical Endoscopy.2014; 47(5): 432. CrossRef
Intérêt de l’échographie pour la prise en charge des syndromes douloureux chroniques
É. J. Viel, J. Lhermite, L. Cherfi
Douleur et Analgésie.2013; 26(2): 62. CrossRef
Preparation and Patient Evaluation for Safe Gastrointestinal Endoscopy
Seong Hee Kang, Jong Jin Hyun
Clinical Endoscopy.2013; 46(3): 212. CrossRef
Imaging pancreatobiliary ductal system with optical coherence tomography: A review
Mohammad S Mahmud
World Journal of Gastrointestinal Endoscopy.2013; 5(11): 540. CrossRef
A Case of Left Adrenal Gland Metastatic Cancer Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration
Jae Young Oh, Eui Jung Kim, Jung Eun Song, Byung Ho Kim, Hyun-Sik Hwang, Jin Tae Jung, Joong Goo Kwon, Eun Young Kim
The Korean Journal of Helicobacter and Upper Gastrointestinal Research.2012; 12(3): 202. CrossRef
Introduction; Value of Endoscopic Ultrasound-Guided Fine Needle Aspiration
Eun Young Kim
Clinical Endoscopy.2012; 45(2): 115. CrossRef

6,680 View
49 Download
8 Crossref

Remimazolam, a novel drug, for safe and effective endoscopic sedation: Jae Min Lee, Yehyun Park, Dong Won Ahn, Jun Kyu Lee, Kwang Hyuck Lee; Received February 7, 2024 Accepted May 8, 2024 Published online June 17, 2024; DOI: https://doi.org/10.5946/ce.2024.026

Abstract PubReader ePub: Remimazolam is a novel benzodiazepine with unique pharmacokinetic and pharmacodynamic properties, making it an ideal candidate for sedation during endoscopic procedures. Distinguished by its rapid onset and short duration of action, remimazolam offers a safer and more efficient alternative to traditional sedatives, such as midazolam and propofol, with fewer side effects, such as hypotension, bradycardia, and respiratory depression. This article reviews the characteristics of remimazolam and its practical advantages, including ease of use, quick recovery time, and minimal residual sedation, emphasizing its potential to improve patient safety and procedural efficiency in clinical endoscopy settings.

0 View
0 Download

Author index